Abstract
Background: Array Comparative Genomic Hybridization (array CGH) is increasingly applied on DNA obtained from formalin-fixed paraffin-embedded (FFPE) tissue, but in a proportion of cases this type of DNA is unsuitable. Due to the high experimental costs of array CGH and unreliable methods for DNA quality testing, better prediction methods are needed. The aim of this study was to accurately determine the quality of FFPE DNA input in order to predict quality of array CGH outcome. Material and Methods: DNA quality was assessed by isothermal amplification and compared to array CGH quality on 59 FFPE gastric cancer samples, one FFPE colorectal cancer sample, two FFPE normal uvula samples, one fresh frozen and six FFPE HNSCC samples. Gastric cancer DNA was also quality tested by β-globin PCR. Results: Accurate prediction of DNA quality using the isothermal amplification was observed in the colorectal carcinoma, HNSCC and uvula samples. In gastric cancer samples, the isothermal amplification was a more accurate method for selecting good quality DNA for array CGH compared to using PCR product lengths. The isothermal amplification product was used for array CGH and compared to the results achieved using non-amplified DNA in four of the samples. DNAs before and after amplification yielded the same segmentation patterns of chromosomal copy number changes for both the fresh DNA sample and the FFPE samples. Conclusion: The efficiency of isothermal DNA amplification is a reliable predictor for array CGH quality. The amplification product itself can be used for array CGH, even starting with FFPE derived DNA samples.
Highlights
Array Comparative Genomic Hybridization is a powerful method for identifying DNA copy number gains and losses in tumors on a genome-wide scale [9,19]
DNA quality of all 59 gastric cancer (GC) tissue samples was tested using two methods, β-globin PCR and the isothermal amplification, and results of both methods were compared to the median absolute deviation (MAD) value of the array CGH results
Archival formalin-fixed paraffin-embedded (FFPE) tissue samples are an important source for studying large clinical sample sets by array CGH, especially of tumors, since genomic information can be correlated to clinical pathological data and patient outcome
Summary
Array Comparative Genomic Hybridization (array CGH) is a powerful method for identifying DNA copy number gains and losses in tumors on a genome-wide scale [9,19]. Nowadays array CGH is increasingly applied to DNA extracted from formalin-fixed and paraffin-embedded (FFPE) tissue samples [1,3,4,5,10, 14]. Due to the high experimental costs of array CGH and unreliable methods for DNA quality testing, better prediction methods are needed. Material and Methods: DNA quality was assessed by isothermal amplification and compared to array CGH quality on 59 FFPE gastric cancer samples, one FFPE colorectal cancer sample, two FFPE normal uvula samples, one fresh frozen and six FFPE HNSCC samples. The isothermal amplification was a more accurate method for selecting good quality DNA for array CGH compared to using PCR product lengths. The amplification product itself can be used for array CGH, even starting with FFPE derived DNA samples
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
